2/3
07:01 am
pyxs
Pyxis Oncology Announces Interim CEO Appointment and Leadership Transition to Support Strategic Focus and Program Continuity [Yahoo! Finance]
Low
Report
Pyxis Oncology Announces Interim CEO Appointment and Leadership Transition to Support Strategic Focus and Program Continuity [Yahoo! Finance]
2/3
06:45 am
pyxs
Pyxis Oncology Announces Interim CEO Appointment and Leadership Transition to Support Strategic Focus and Program Continuity
Low
Report
Pyxis Oncology Announces Interim CEO Appointment and Leadership Transition to Support Strategic Focus and Program Continuity
1/25
03:05 am
pyxs
Pyxis Oncology (NASDAQ:PYXS) was downgraded by analysts at
Wall Street Z
Neutral
Report
Pyxis Oncology (NASDAQ:PYXS) was downgraded by analysts at
Wall Street Z
1/17
01:11 am
pyxs
Medium
Report
12/20
01:30 am
pyxs
Pyxis Oncology (NASDAQ:PYXS) was downgraded by analysts at
Wall Street Z
Medium
Report
Pyxis Oncology (NASDAQ:PYXS) was downgraded by analysts at
Wall Street Z
12/19
07:02 am
pyxs
Pyxis Oncology (NASDAQ:PYXS) had its "buy" rating reaffirmed by analysts at HC Wainwright.
High
Report
Pyxis Oncology (NASDAQ:PYXS) had its "buy" rating reaffirmed by analysts at HC Wainwright.
12/18
06:02 pm
pyxs
Pyxis Oncology (NASDAQ:PYXS) had its "outperform" rating reaffirmed by analysts at Royal Bank Of Canada.
High
Report
Pyxis Oncology (NASDAQ:PYXS) had its "outperform" rating reaffirmed by analysts at Royal Bank Of Canada.
11/24
08:05 am
pyxs
Pyxis Oncology (NASDAQ:PYXS) had its "overweight" rating reaffirmed by analysts at Stephens.
Medium
Report
Pyxis Oncology (NASDAQ:PYXS) had its "overweight" rating reaffirmed by analysts at Stephens.